Home Applications 201917 Application 201917
Type NDA
Sponsor VERTEX PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 INCIVEK TELAPREVIR TABLET;ORAL 375MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N201917-001 INCIVEK TELAPREVIR 375MG TABLET / ORAL 2011-05-23
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N201917-001 8431615 2028-05-30 U-1398 2013-05-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N201917-001 INCIVEK 375MG TABLET / ORAL 2011-05-23 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N201917-001 INCIVEK 375MG TABLET / ORAL 2011-05-23 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N201917-001 INCIVEK 375MG TABLET / ORAL 2011-05-23 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N201917-001 INCIVEK 375MG TABLET / ORAL 2011-05-23 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N201917-001 INCIVEK 375MG TABLET / ORAL 2011-05-23 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 93 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 c2088c7a36db…2026-09-14 22:38:34 2026-08 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N201917-001 8529882 2021-08-31 U-1398 2013-10-09 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N201917-001 7820671 2025-02-25 Drug substance, Drug product 2011-06-20 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N201917-001 8431615 2028-05-30 U-1398 2013-05-29 74a2ff9319b5…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.